Balancing benefits and harms: the example of non-steroidal anti-inflammatory drugs
- PMID: 15231619
- PMCID: PMC443450
- DOI: 10.1136/bmj.329.7456.31
Balancing benefits and harms: the example of non-steroidal anti-inflammatory drugs
Figures
Comment in
-
Balancing benefits and harms in health care: technology to collect and share information about harms already exists.BMJ. 2004 Aug 21;329(7463):457; discussion 458-9. doi: 10.1136/bmj.329.7463.457. BMJ. 2004. PMID: 15321908 Free PMC article. No abstract available.
-
Balancing benefits and harms in health care: ethical dimension was not discussed in theme issue.BMJ. 2004 Aug 21;329(7463):458; discussion 458-9. doi: 10.1136/bmj.329.7463.458. BMJ. 2004. PMID: 15321912 Free PMC article. No abstract available.
References
-
- Lawrence R, Helmick CG, Arnett FC, Deyo RA, Felson DT, Gianni EH, et al. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum 1998;41: 778-99. - PubMed
-
- Evans JM, McDevitt DG, MacDonald TM. The Tayside Medicines Monitoring Unit (MEMO): a record-linkage system for pharmacovigilance. Pharmceut Med 2000;9: 177-84.
-
- Bartlett C, Doyal L, Ebrahim S, Davey P, Bachmann M, Egger M, et al. The causes and effects of socio-demographic exclusions from clinical trials. Health Technol Assess Rep (in press). - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources